Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1990 1
1991 2
1992 1
1994 1
1995 1
1996 1
1997 2
1998 3
1999 1
2000 5
2001 1
2002 3
2003 3
2004 3
2005 6
2006 1
2007 4
2008 4
2009 3
2010 2
2011 1
2012 6
2013 6
2014 3
2015 4
2016 5
2017 3
2018 2
2019 2
2020 5
2021 3
2022 6
2023 7
2024 5
2025 10
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
Barnes DR, Silvestri V, Leslie G, McGuffog L, Dennis J, Yang X, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arason A, Arnold N, Auber B, Azzollini J, Balmaña J, Barkardottir RB, Barrowdale D, Barwell J, Belotti M, Benitez J, Berthet P, Boonen SE, Borg Å, Bozsik A, Brady AF, Brennan P, Brewer C, Brunet J, Bucalo A, Buys SS, Caldés T, Caligo MA, Campbell I, Cassingham H, Christensen LL, Cini G, Claes KBM; GEMO Study Collaborators; EMBRACE Collaborators; Cook J, Coppa A, Cortesi L, Damante G, Darder E, Davidson R, de la Hoya M, De Leeneer K, de Putter R, Del Valle J, Diez O, Ding YC, Domchek SM, Donaldson A, Eason J, Eeles R, Engel C, Evans DG, Feliubadaló L, Fostira F, Frone M, Frost D, Gallagher D, Gehrig A, Giraud S, Glendon G, Godwin AK, Goldgar DE, Greene MH, Gregory H, Gross E, Hahnen E, Hamann U, Hansen TVO, Hanson H, Hentschel J, Horvath J; KConFab Investigators; HEBON Investigators; Izatt L, Izquierdo A, James PA, Janavicius R, Jensen UB, Johannsson OT, John EM, Kramer G, Kroeldrup L, Kruse TA, Lautrup C, Lazaro C, Lesueur F, Lopez-Fernández A, Mai PL, Manoukian S, Matrai Z, Matricardi L, Maxwell KN, Mebirouk N, Meindl A, Montagna M, Monteiro AN, Morris… See abstract for full author list ➔ Barnes DR, et al. Among authors: christensen ll. J Natl Cancer Inst. 2022 Jan 11;114(1):109-122. doi: 10.1093/jnci/djab147. J Natl Cancer Inst. 2022. PMID: 34320204 Free PMC article.
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Barnes DR, Rookus MA, McGuffog L, Leslie G, Mooij TM, Dennis J, Mavaddat N, Adlard J, Ahmed M, Aittomäki K, Andrieu N, Andrulis IL, Arnold N, Arun BK, Azzollini J, Balmaña J, Barkardottir RB, Barrowdale D, Benitez J, Berthet P, Białkowska K, Blanco AM, Blok MJ, Bonanni B, Boonen SE, Borg Å, Bozsik A, Bradbury AR, Brennan P, Brewer C, Brunet J, Buys SS, Caldés T, Caligo MA, Campbell I, Christensen LL, Chung WK, Claes KBM, Colas C; GEMO Study Collaborators; EMBRACE Collaborators; Collonge-Rame MA, Cook J, Daly MB, Davidson R, de la Hoya M, de Putter R, Delnatte C, Devilee P, Diez O, Ding YC, Domchek SM, Dorfling CM, Dumont M, Eeles R, Ejlertsen B, Engel C, Evans DG, Faivre L, Foretova L, Fostira F, Friedlander M, Friedman E, Frost D, Ganz PA, Garber J, Gehrig A, Gerdes AM, Gesta P, Giraud S, Glendon G, Godwin AK, Goldgar DE, González-Neira A, Greene MH, Gschwantler-Kaulich D, Hahnen E, Hamann U, Hanson H, Hentschel J, Hogervorst FBL, Hooning MJ, Horvath J, Hu C, Hulick PJ, Imyanitov EN; kConFab Investigators; HEBON Investigators; GENEPSO Investigators; Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James PA, Janavicius R, John EM, Joseph V, Karlan BY, Kast K, Koudijs M, Kruse … See abstract for full author list ➔ Barnes DR, et al. Among authors: christensen ll. Genet Med. 2020 Oct;22(10):1653-1666. doi: 10.1038/s41436-020-0862-x. Epub 2020 Jul 15. Genet Med. 2020. PMID: 32665703 Free PMC article.
Changes in Adrenal Function and Insufficiency Symptoms After Cessation of Prednisolone.
Hansen SB, Dreyer AF, Jørgensen NT, Al-Jorani H, Bislev LS, Boesen VB, Borresen SW, Christensen LL, Glintborg D, Hauge EM, Hetland ML, Jensen RC, Just SA, Keller KK, Klose M, Laugesen K, Locht H, Lund ML, Stankovic J, Stewart PM, Tei RMH, Voss A, Feldt-Rasmussen U, Jørgensen JOL, Andersen MS. Hansen SB, et al. Among authors: christensen ll. JAMA Netw Open. 2025 Mar 3;8(3):e251029. doi: 10.1001/jamanetworkopen.2025.1029. JAMA Netw Open. 2025. PMID: 40100216 Free PMC article. Clinical Trial.
Acromegaly management in the Nordic countries: A Delphi consensus survey.
Arlien-Søborg MC, Dal J, Heck A, Stochholm K, Husted E, Feltoft CL, Rasmussen ÅK, Feldt-Rasmussen U, Andreassen M, Klose MC, Nielsen TL, Andersen MS, Christensen LL, Krogh J, Jarlov A, Bollerslev J, Nermoen I, Oksnes M, Dahlqvist P, Olsson T, Berinder K, Hoybye C, Petersson M, Akerman AK, Wahlberg J, Ekman B, Engstrom BE, Johannsson G, Ragnarsson O, Olsson D, Sigurjónsdóttir HÁ, Fougner SL, Matikainen N, Vehkavaara S, Metso S, Jaatinen P, Hämäläinen P, Rintamäki R, Yliaska I, Immonen H, Mäkimattila S, Cederberg-Tamminen H, Viukari M, Nevalainen P, Nuutila P, Schalin-Jäntti C, Burman P, Jørgensen JOL. Arlien-Søborg MC, et al. Among authors: christensen ll. Clin Endocrinol (Oxf). 2024 Sep;101(3):263-273. doi: 10.1111/cen.15095. Epub 2024 Jun 12. Clin Endocrinol (Oxf). 2024. PMID: 38865284
Illicit Anabolic Steroid Use and Cardiovascular Status in Men and Women.
Buhl LF, Christensen LL, Hjortebjerg R, Hasific S, Hjerrild C, Harders S, Lillevang-Johansen M, Glintborg D, Andersen MS, Thevis M, Kistorp C, Rasmussen JJ, Lindholt JS, Diederichsen ACP, Frystyk J. Buhl LF, et al. Among authors: christensen ll. JAMA Netw Open. 2025 Aug 1;8(8):e2526636. doi: 10.1001/jamanetworkopen.2025.26636. JAMA Netw Open. 2025. PMID: 40880090 Free PMC article.
Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study.
Kostov AM, Jensen MB, Ejlertsen B, Thomassen M, Rossing M, Pedersen IS, Petersen AH, Christensen LL, Wadt KAW, Berrocal-Almanza LC, Miranda M, Lænkholm AV. Kostov AM, et al. Among authors: christensen ll. Breast Cancer Res Treat. 2025 Jul;212(2):309-323. doi: 10.1007/s10549-025-07726-2. Epub 2025 May 23. Breast Cancer Res Treat. 2025. PMID: 40408052 Free PMC article.
109 results